Keywords: USA, FDA, Industry relations, Communication, PDUFA, User fees, R&D costs

US FDA and life sciences industry relationship complicated by new science and changing expectations, PwC survey reveals

Article | 01 December 2010

Growing public demand for increased drug and medical device safety, as well as the need to develop medical products faster, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in